These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 16917003)
1. Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Hoffmann P; Eder R; Boeld TJ; Doser K; Piseshka B; Andreesen R; Edinger M Blood; 2006 Dec; 108(13):4260-7. PubMed ID: 16917003 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-7 matures suppressive CD127(+) forkhead box P3 (FoxP3)(+) T cells into CD127(-) CD25(high) FoxP3(+) regulatory T cells. Di Caro V; D'Anneo A; Phillips B; Engman C; Harnaha J; Lakomy R; Styche A; Trucco M; Giannoukakis N Clin Exp Immunol; 2011 Jul; 165(1):60-76. PubMed ID: 21413939 [TBL] [Abstract][Full Text] [Related]
3. Regulation of trafficking receptor expression in human forkhead box P3+ regulatory T cells. Lim HW; Broxmeyer HE; Kim CH J Immunol; 2006 Jul; 177(2):840-51. PubMed ID: 16818738 [TBL] [Abstract][Full Text] [Related]
4. Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. Hoffmann P; Eder R; Kunz-Schughart LA; Andreesen R; Edinger M Blood; 2004 Aug; 104(3):895-903. PubMed ID: 15090447 [TBL] [Abstract][Full Text] [Related]
5. Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression. Hiura T; Kagamu H; Miura S; Ishida A; Tanaka H; Tanaka J; Gejyo F; Yoshizawa H J Immunol; 2005 Oct; 175(8):5058-66. PubMed ID: 16210609 [TBL] [Abstract][Full Text] [Related]
6. Low expression of CD39(+) /CD45RA(+) on regulatory T cells (Treg ) cells in type 1 diabetic children in contrast to high expression of CD101(+) /CD129(+) on Treg cells in children with coeliac disease. Åkesson K; Tompa A; Rydén A; Faresjö M Clin Exp Immunol; 2015 Apr; 180(1):70-82. PubMed ID: 25421756 [TBL] [Abstract][Full Text] [Related]
7. CD45RA Distinguishes CD4+CD25+CD127-/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression. Arroyo Hornero R; Betts GJ; Sawitzki B; Vogt K; Harden PN; Wood KJ Transplantation; 2017 Feb; 101(2):302-309. PubMed ID: 28118317 [TBL] [Abstract][Full Text] [Related]
8. Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin. Strauss L; Whiteside TL; Knights A; Bergmann C; Knuth A; Zippelius A J Immunol; 2007 Jan; 178(1):320-9. PubMed ID: 17182569 [TBL] [Abstract][Full Text] [Related]
9. CD8+CD45RA+CCR7+FOXP3+ T cells with immunosuppressive properties: a novel subset of inducible human regulatory T cells. Suzuki M; Jagger AL; Konya C; Shimojima Y; Pryshchep S; Goronzy JJ; Weyand CM J Immunol; 2012 Sep; 189(5):2118-30. PubMed ID: 22821963 [TBL] [Abstract][Full Text] [Related]
10. The plasticity and stability of regulatory T cells. Sakaguchi S; Vignali DA; Rudensky AY; Niec RE; Waldmann H Nat Rev Immunol; 2013 Jun; 13(6):461-7. PubMed ID: 23681097 [TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid hormone differentially modulates the in vitro expansion and cytokine profile of thymic and splenic Treg cells. Pap R; Ugor E; Litvai T; Prenek L; Najbauer J; Németh P; Berki T Immunobiology; 2019 Mar; 224(2):285-295. PubMed ID: 30612787 [TBL] [Abstract][Full Text] [Related]
12. Autologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survival. Dobrzanski MJ; Rewers-Felkins KA; Quinlin IS; Samad KA; Phillips CA; Robinson W; Dobrzanski DJ; Wright SE Clin Immunol; 2009 Dec; 133(3):333-52. PubMed ID: 19762283 [TBL] [Abstract][Full Text] [Related]
13. Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease. Canavan JB; Scottà C; Vossenkämper A; Goldberg R; Elder MJ; Shoval I; Marks E; Stolarczyk E; Lo JW; Powell N; Fazekasova H; Irving PM; Sanderson JD; Howard JK; Yagel S; Afzali B; MacDonald TT; Hernandez-Fuentes MP; Shpigel NY; Lombardi G; Lord GM Gut; 2016 Apr; 65(4):584-94. PubMed ID: 25715355 [TBL] [Abstract][Full Text] [Related]
14. IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. Zheng SG; Wang J; Wang P; Gray JD; Horwitz DA J Immunol; 2007 Feb; 178(4):2018-27. PubMed ID: 17277105 [TBL] [Abstract][Full Text] [Related]
15. Helios+ and Helios- cells coexist within the natural FOXP3+ T regulatory cell subset in humans. Himmel ME; MacDonald KG; Garcia RV; Steiner TS; Levings MK J Immunol; 2013 Mar; 190(5):2001-8. PubMed ID: 23359504 [TBL] [Abstract][Full Text] [Related]
16. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity. Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341 [TBL] [Abstract][Full Text] [Related]
17. Lower numbers of FoxP3 and CCR4 co-expressing cells in an elevated subpopulation of CD4+CD25high regulatory T cells from Wegener's granulomatosis. Klapa S; Mueller A; Csernok E; Fagin U; Klenerman P; Holl-Ulrich K; Gross WL; Lamprecht P Clin Exp Rheumatol; 2010; 28(1 Suppl 57):72-80. PubMed ID: 20412707 [TBL] [Abstract][Full Text] [Related]
18. Enhanced engagement of CTLA-4 induces antigen-specific CD4+CD25+Foxp3+ and CD4+CD25- TGF-beta 1+ adaptive regulatory T cells. Li R; Perez N; Karumuthil-Melethil S; Prabhakar BS; Holterman MJ; Vasu C J Immunol; 2007 Oct; 179(8):5191-203. PubMed ID: 17911604 [TBL] [Abstract][Full Text] [Related]
19. Identification of a human Th1-like IFNγ-secreting Treg subtype deriving from effector T cells. Venigalla RK; Guttikonda PJ; Eckstein V; Ho AD; Sertel S; Lorenz HM; Tretter T J Autoimmun; 2012 Dec; 39(4):377-87. PubMed ID: 22824211 [TBL] [Abstract][Full Text] [Related]